Results 221 to 230 of about 2,327,584 (298)

Real‐World Outcomes of Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Oral Cavity, Pharynx, and Larynx: An Australian Population‐Based Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Nivolumab is an immune checkpoint inhibitor used for recurrent/metastatic squamous cell carcinoma (SCC) of the oral cavity, pharynx, and larynx; yet Australian real‐world evidence remains limited. Methods A retrospective cohort study was conducted using linked Pharmaceutical Benefits Scheme dispensing and National Death Index ...
Phoebe L. Sault   +3 more
wiley   +1 more source

EUSICA/INSICA Position Paper on Squamous Cell Carcinoma of the Nasal Vestibule: A Distinct Clinical Entity Requiring Dedicated Classification, Treatment Strategies and Outcome Measures

open access: yesHead &Neck, EarlyView.
ABSTRACT Purpose Cancer of the nasal vestibule (CNV) differs anatomically and clinically from both sinonasal and cutaneous squamous cell carcinoma, yet lacks formal recognition as a separate clinical entity and topographical subsite; whether it is also biologically distinct has not yet been investigated.
Mischa de Ridder   +24 more
wiley   +1 more source

Saliency-Curated Deep Learning for Predicting Receptor Status in Breast Cancer Brain Metastases. [PDF]

open access: yesJ Clin Med
Christodoulou RC   +7 more
europepmc   +1 more source

Outcomes and adverse events of postoperative stereotactic interventional radiotherapy/brachytherapy for brain metastases: a systematic review. [PDF]

open access: yesRadiol Med
Bilski M   +16 more
europepmc   +1 more source

Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases. [PDF]

open access: yesCancer Res Commun
Contreras-Zárate MJ   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy